
Aptose Biosciences (APTO) Earnings Dates & Reports
Aptose Biosciences (APTO) Most Recent Earnings
Report Date
Period EndingQ3 2024
Est. EPS-$35.70
Actual EPS-$11.10
EarningsBeat
Aptose Biosciences (APTO) Earnings
View the latest Aptose Biosciences (APTO) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Aptose Biosciences (APTO)
Order type
Buy in
Order amount
Est. shares
0 shares
Aptose Biosciences (APTO) Earnings per Share (EPS) History
Signup for full accessBrowse free
Aptose Biosciences (APTO) Latest Earnings
The value each APTO share was expected to gain vs. the value each share gained.
Aptose Biosciences (APTO) reported its most recent earnings on for Q3 2024, posting earnings per share (EPS) of -$11.10. This exceeded analysts' expectations of -$35.70 by 68.91%, marking a Beat.
For comparison, Aptose Biosciences reported EPS of -$52.80 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
Aptose Biosciences (APTO) Earnings History
Aptose Biosciences (APTO) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Aptose Biosciences’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Aptose Biosciences (APTO) Earnings FAQs
Aptose Biosciences (APTO) last reported earnings on Nov 8, 2024 for Q3 2024, posting an EPS of -$11.10, which Beat the estimate of -$35.70 by 68.91%.
For Q3 2024, Aptose Biosciences (APTO) reported an EPS of -$11.10, exceeding analysts' estimate of -$35.70 by 68.91%.
For Q3 2024, Aptose Biosciences (APTO) Beat expectations with an actual EPS of -$11.10 vs. an estimated EPS of -$35.70.
Following the last earnings report on Nov 8, 2024, Aptose Biosciences (APTO)'s stock price moved — from — to —.
The next Aptose Biosciences (APTO) earnings call is scheduled for Nov. 8, 2024, where executives will discuss financial results and outlook.